QIM
IBB icon

Quantitative Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Quantitative Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.32M Buy
+37,419
New +$6.4M 0.66% 40
2025
Q4 		– Sell
-4,362
Closed -$629K – 464
2025
Q3 		$629K Buy
4,362
+2,734
+168% +$373K 0.09% 202
2025
Q2 		$205K Buy
+1,628
New +$200K 0.03% 285
2024
Q3 		– Sell
-18,071
Closed -$2.48M – 375
2024
Q2 		$2.48M Buy
+18,071
New +$2.41M 0.27% 78
2022
Q4 		– Sell
-25,485
Closed -$2.98M – 267
2022
Q3 		$2.98M Sell
25,485
-60,962
-71% -$7.57M 0.49% 42
2022
Q2 		$10.2M Buy
+86,447
New +$10.3M 1.55% 11
2021
Q2 		– Sell
-71,758
Closed -$10.8M – 486
2021
Q1 		$10.8M Buy
71,758
+36,890
+106% +$5.86M 0.91% 24
2020
Q4 		$5.28M Buy
+34,868
New +$4.98M 0.43% 47
2018
Q4 		– Sell
-7,500
Closed -$914K – 694
2018
Q3 		$914K Sell
7,500
-72,700
-91% -$8.56M 0.03% 320
2018
Q2 		$8.81M Buy
+80,200
New +$8.58M 0.18% 117
2017
Q4 		– Sell
-357,300
Closed -$39.7M – 811
2017
Q3 		$39.7M Sell
357,300
-644,100
-64% -$68.8M 0.45% 42
2017
Q2 		$104M Buy
+1,001,400
New +$98.6M 1.56% 7
2016
Q4 		– Sell
-35,100
Closed -$3.39M – 857
2016
Q3 		$3.39M Buy
+35,100
New +$3.34M 0.11% 220
2016
Q2 		– Sell
-91,800
Closed -$7.98M – 833
2016
Q1 		$7.98M Buy
91,800
+57,600
+168% +$5.15M 0.39% 53
2015
Q4 		$3.86M Sell
34,200
-350,700
-91% -$38.1M 0.23% 113
2015
Q3 		$38.9M Buy
+384,900
New +$46.2M 2.93% 1
2015
Q1 		– Sell
-28,200
Closed -$2.85M – 676
2014
Q4 		$2.85M Buy
+28,200
New +$2.74M 0.44% 48
2014
Q2 		– Sell
-656,400
Closed -$51.7M – 549
2014
Q1 		$51.7M Buy
+656,400
New +$54.7M 2.46% 7
2013
Q4 		– Sell
-17,400
Closed -$1.22M – 645
2013
Q3 		$1.22M Sell
17,400
-26,700
-61% -$1.75M 0.11% 185
2013
Q2 		$2.56M Buy
+44,100
New +$2.55M 0.45% 39

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Quantitative Investment Management's IBB Position: Q1 2026 in Review

Quantitative Investment Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 37,419 shares worth $6.32M. The stake represents 0.66% of the portfolio and ranks #40 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in IBB as recently as Q3 2025.

Quantitative Investment Management first reported a position in IBB in Q2 2013 and has held it in 20 quarters since. The position peaked at $104M in Q2 2017. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Quantitative Investment Management held 37,419 shares of iShares Biotechnology ETF worth $6.32M as of Q1 2026.
  • iShares Biotechnology ETF was a new Quantitative Investment Management position in Q1 2026.
  • iShares Biotechnology ETF made up 0.66% of Quantitative Investment Management's portfolio in Q1 2026, its #40 holding.
  • Quantitative Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 20 quarters since.
  • Quantitative Investment Management's iShares Biotechnology ETF position peaked at $104M in Q2 2017.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.